SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $498,967 | +5.5% | 5,541 | +8.3% | 0.01% | 0.0% |
| Q3 2021 | $473,128 | +15.2% | 5,116 | -3.2% | 0.01% | +16.7% |
| Q2 2021 | $410,778 | +0.7% | 5,284 | -3.5% | 0.01% | 0.0% |
| Q1 2021 | $407,977 | -58.2% | 5,474 | -4.3% | 0.01% | -60.0% |
| Q4 2020 | $975,203 | +20.5% | 5,720 | -0.8% | 0.02% | +7.1% |
| Q3 2020 | $809,439 | -14.6% | 5,764 | -2.5% | 0.01% | -17.6% |
| Q2 2020 | $948,090 | +95.9% | 5,913 | +19.5% | 0.02% | +70.0% |
| Q1 2020 | $483,916 | -26.5% | 4,947 | -3.1% | 0.01% | -9.1% |
| Q4 2019 | $658,491 | +68.2% | 5,103 | -1.8% | 0.01% | +57.1% |
| Q3 2019 | $391,513 | -47.3% | 5,198 | +6.3% | 0.01% | -46.2% |
| Q2 2019 | $743,036 | +24.6% | 4,890 | -2.3% | 0.01% | +18.2% |
| Q1 2019 | $596,308 | +7.0% | 5,003 | -2.0% | 0.01% | 0.0% |
| Q4 2018 | $557,327 | -28.8% | 5,107 | +5.4% | 0.01% | -21.4% |
| Q3 2018 | $782,677 | -99.9% | 4,846 | -0.6% | 0.01% | +40.0% |
| Q2 2018 | $644,246,000 | -54.7% | 4,874 | -74.6% | 0.01% | -50.0% |
| Q1 2018 | $1,422,305,000 | +135357.6% | 19,197 | +1.8% | 0.02% | +42.9% |
| Q4 2017 | $1,050,000 | -41.2% | 18,864 | -52.1% | 0.01% | +27.3% |
| Q3 2017 | $1,787,000 | +49.4% | 39,393 | +11.0% | 0.01% | +37.5% |
| Q2 2017 | $1,196,000 | +13.8% | 35,493 | 0.0% | 0.01% | +14.3% |
| Q1 2017 | $1,051,000 | +7.9% | 35,493 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $974,000 | -50.1% | 35,493 | +11.7% | 0.01% | -50.0% |
| Q3 2016 | $1,951,000 | +221.9% | 31,776 | 0.0% | 0.01% | +250.0% |
| Q2 2016 | $606,000 | -2.3% | 31,776 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $620,000 | -49.4% | 31,776 | 0.0% | 0.01% | -44.4% |
| Q4 2015 | $1,226,000 | +32.0% | 31,776 | +9.8% | 0.01% | +28.6% |
| Q3 2015 | $929,000 | +2.7% | 28,934 | -2.7% | 0.01% | +16.7% |
| Q2 2015 | $905,000 | +115.5% | 29,736 | -6.0% | 0.01% | +100.0% |
| Q1 2015 | $420,000 | -8.3% | 31,649 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $458,000 | -31.4% | 31,649 | 0.0% | 0.00% | -40.0% |
| Q3 2014 | $668,000 | -29.2% | 31,649 | 0.0% | 0.01% | -28.6% |
| Q2 2014 | $943,000 | +26.4% | 31,649 | +2.0% | 0.01% | +40.0% |
| Q1 2014 | $746,000 | +21.9% | 31,029 | +3.2% | 0.01% | +25.0% |
| Q4 2013 | $612,000 | -52.4% | 30,059 | +10.3% | 0.00% | -60.0% |
| Q3 2013 | $1,287,000 | +24.1% | 27,244 | 0.0% | 0.01% | +25.0% |
| Q2 2013 | $1,037,000 | – | 27,244 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |